Phagocytosis reduces HIV-1 production in human monocytes/macrophages infected in vitro

G Piedimonte1, M Montroni, G Silvestri

  • 1Institute of General Pathology, University of Parma, Italy.

Archives of Virology
|January 1, 1993
PubMed

Insights

Activating human macrophages with particles or phorbol ester significantly reduces HIV release and transmission from infected cells. This finding offers potential new strategies for controlling HIV infection in macrophages.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • Macrophages play a crucial role in HIV pathogenesis.
  • HIV-infected macrophages can serve as a reservoir and contribute to viral spread.
  • Understanding cellular activation effects on HIV replication is vital.

Purpose of the Study:

  • To investigate the impact of activating monocytes-derived human macrophages (MDHM) on HIV replication and transmission.
  • To determine if specific activation methods can inhibit viral release from infected MDHM.

Main Methods:

  • In vitro culture of human macrophages.
  • Activation of macrophages using ingestible particles (opsonized erythrocytes, latex beads) or phorbol ester.
  • Assessment of virion release from HIV-infected MDHM.
  • Evaluation of HIV transmission to cocultured CD4-positive CEM cells.

Main Results:

  • Macrophage activation by particles or phorbol ester significantly reduced virion release from HIV-infected MDHM.
  • Activated MDHM showed a markedly reduced ability to transmit HIV to CEM cells.
  • This suggests a mechanism for controlling viral load within macrophage reservoirs.

Conclusions:

  • In vitro activation of human macrophages can effectively suppress HIV production and cell-to-cell transmission.
  • Targeting macrophage activation pathways may represent a novel therapeutic approach for HIV/AIDS management.